See every side of every news story
Published loading...Updated

Amgen's Five Prime Takeover Delivers Gastric Cancer Win

Summary by Pharmaphorum
Four years after buying Five Prime for $1.9bn, Amgen has promising phase 3 results with a gastric cancer drug that was the focal point for the deal

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Monday, June 30, 2025.
Sources are mostly out of (0)